ROME
ROME Therapeutics is illuminating the dark genome to pioneer a new approach to treating serious diseases.
Sector
Life Sciences
Date Invested
2019
Investor
Krishna Yeshwant (left)
First Round
Series A
Founder & CEO
Rosana Kapeller (right)
Website